Patients With HR-Positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
December 08, 2023
December 08, 2023
SAN ANTONIO, Texas, Dec. 8 (TNSres) -- The American Association for Cancer Research posted the following news release:
* * *
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive
* * *
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused end . . .
* * *
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive
* * *
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused end . . .